Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

RCS-01 cell therapy is safe and improves skin gene expression.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Oral baricitinib is effective and safe for treating alopecia areata.

Alopecia areata management in Poland faces challenges in treatment consistency and patient care, needing standardized practices and better public awareness.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

Ritlecitinib improves hair growth and quality of life in severe alopecia areata with longer use.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

High levels of human keratin 16 in mice cause skin lesions and abnormal skin development.

HPV-150 and HPV-151 are rare skin viruses linked to warts and some skin cancers.

Two cases of hairy elbows syndrome were described, with normal skin texture and symmetrical hair growth.

A new tool helps study hair follicle cells to develop better treatments for hair disorders.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Oral JAK inhibitors effectively regrow hair in alopecia areata with a good safety profile.

Combining scalp acupoint catgut embedding with 5% minoxidil may help treat male pattern baldness.